ArticleInvestigational new drugs2021

Effects of rifampicin on the pharmacokinetics of alflutinib, a selective third-generation EGFR kinase inhibitor, and its metabolite AST5902 in healthy volunteers.

Yun-Ting Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.